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ABSTRACT 
Objective: In this paper, a mathematical model with the new insulin system for describing the modified oral minimal model of glucose plasma levels is 
introduced. This model is combined with non linear least-squares method is used to analyze the results of the oral glucose tolerance test (OGTT) in humans. 
Methods: We used this model to analyze the published data of OGTT test to study 741 subjects, including normal glucose tolerance (NGT), impaired 
glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) subjects. Reducing the number of blood glucose samples needed and the duration of 
the tests is necessary to enhance the usability of the mathematical model. In this work, the model was to extrapolate sample data to reduce the 
number of samples and duration of the OGTT test. 
Results: The estimated results from this model for glucose sample showed the good correlation to the reference data. The results showed that the 
180 min 4glucose sample could provide a reasonable basis to enhance the use of the modified oral minimal model approach to NGT, IGT and T2DM 
subjects. The averaged R2 value between experimental and calculated plasma concentrations is 0.960, which indicates excellent agreement. 
Conclusion: The averaged R2 value is 0.960, it indicates that a reduction in sample data is possible by using the modified oral minimal model 
approach to diagnosis of NGT, IGT and T2DM subjects. 
Keywords: Diabetes mellitus, Mathematical model, Modified oral minimal model, Oral glucose tolerance test. 
 
INTRODUCTION 
In previous work [1, 2], we introduced a modified minimal model, 
proposed in the evaluation of data obtained in the intravenous 
glucose tolerance test (IVGT). However, this model does not describe 
the condition of the body actually. The purpose of the present study 
is to develop a mathematical model in the evaluation of published 
data from the oral glucose tolerance test (OGTT), capable of account 
for the effect of the gastric emptying process on glycemia in OGTT. 
An OGTT is a screening test that involves the measurement of a 
subject's plasma glucose level after subject drinks a solution 
containing 75 grams of glucose. Blood samples were collected at 0, 5, 
10, 20, 30, 40, 50, 60, 75, 90, 120, 150, 180, 210, 240 and 300 min. 
This test is commonly used to confirm a diagnosis of diabetes 
mellitus or gestational diabetes and other metabolic diseases. 
The modified oral minimal model is used to process the OGTT data to 
assess physiological functions, such as insulin sensitivity and glucose 
effectiveness, by analyzing the dynamics of plasma glucose. The OGTT is 
a common clinical test used to examine glucose tolerance under 
exogenous glucose load. After overnight fasting in the morning, a fasting 
blood sample of the subject is taken. Then, the subject receives glucose 
orally and blood samples are taken again. For instance, glucose 
concentration 180 min are de fined as a diagnostic criterion of diabetes 
mellitus, an oral glucose load was applied at time 0. 
At previous work, the model will be validated on 300 min OGTT 
procedures in which plasma glucose levels have been sampled. 
However, such a sizeable number of samples and the prolonged 
period of study are not feasible in daily practice or large population-
based studies. Hence, OGTT procedure that does not require a long 
time required to be done as an alternative [3]. 
The aim of this work was to extrapolate sample data to reduce the 
number of samples and period of the OGTT test, and to enhance the 
usability of the modified oral minimal model approach to diagnose 
of diabetes mellitus subjects. Glucose concentration at 180 to 200 
min was extrapolated using a nonlinear least-squares method. The 
OGTT data from 741 subjects in various stages of glucose tolerance 
in references [3, 4] were analyzed to evaluate the estimation 
accuracy. 
MATERIALS AND METHODS 
The published data from 741 subjects who had undergone an OGTT 
for clinical purposes at the RenJi Hospital in Shanghai, China was 
retrospectively analyzed. The data set consisted of 441 type 2 
diabetes mellitus (T2DM) subjects, 167 impaired glucose tolerance 
(IGT) subjects, commonly called pre-diabetes, and 133 normal 
glucose tolerance (NGT) subjects. The characteristics of the subjects 
are shown in table 1 [3, 4]. 
 
Table 1: Subject characteristics of the published data [3, 4] 
 NGT IGT T2DM 
Basal Glucose (mg/dl) 90.2±9.3 104.8±12.4 143.3±40.0 
Basal Insulin (μU/ml) 8.2±3.5 11.5±9.6 13.5±10.6 
Age (years) 45.8±13.8 55.5±12.0 57.2±11.9 
BMI (kg/m2) 23.6±3.5 25.1±3.4 24.9±3.5 
mean±SD 
 
Insulin is the key regulator of glucose level. For this reason, the 
dynamics of the glucose and insulin system in the OGTT are often 
selected for the model assessment of diabetes mellitus. In this study, 
the analysis of the OGTT studies can be used the modified oral 
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minimal model. Whereas during the OGTT glucose enters the 
systemic circulation directly, during the OGTT glucose is ingested, 
encounter the systemic circulation only after absorption from the 
gastrointestinal tract and passage through the liver. An explicit 
description about the absorption rate of glucose of exogenous 
glucose in the modified oral minimal model can be expressed with 




= −�p1 + X(t)�G(t) + p1Gb +
Rα(t)
V
,G0 = Gb,(1) 
dX(t)
dt





(t − ti−1); ti−1 ≤ t ≤ ti, i = 1, … , 8 
 0;  otherwise 
 ,(3) 
Where Rα(t) is the generic expression for the rate of entry of 
exogenous glucose into the systemic circulation per unit BW 
(milligrams per kg/min). During the OGTT, Rα(t) coincides with the 
impulse injection of a glucose dose (milligrams per kg) and the rate 
of absorbed glucose. 
The parameters or variables that are used in equations (1)-(3) above 
are: G (t) is the plasma glucose concentration (milligrams per 
deciliter (mg/dl)), with GB denoting its basal glucose, X(t) is insulin 
action (min-1) exerted on glucose disposal from an insulin 
compartment, remote from plasma, I(t) is the plasma insulin 
concentration (micro units per ml (μU/ml)), with Ib denoting its 
basal insulin, V is the glucose distribution volume per unit BW 
(milliliters per kg (ml/kg)). Parameter p1 represents the fractional 
ability of glucose to lower its own concentration in plasma. 
Parameter p2 (min-1) governs the speed of rise and decay of insulin 
action, and p3 (min-2 per μU/ml) governs its size. 
Insulin is cleared from the plasma compartment at a rate 
proportional to the amount of insulin in the plasma compartment. 
The modified oral minimal model for insulin kinetics is given by the 
ordinary differential equations [1, 2]: 
dI(t)
dt
= γ(G(t) − Gb)t − k(I(t)− Ib), I0 = Ib,if G(t)>Gb,(4) 
dI(t)
dt
= −k(I(t)− Ib),I0 = Ib, if G(t)<Gb,(5) 
Where k is the insulin clearance fraction, Gb is the basal glucose 
level, and γ is a measure of the secondary pancreatic response to 
glucose. 
Parameters p1, p2, p3, k and γ in the modified oral minimal model 
were estimated by a nonlinear least-squares method for glucose 
data collected during an OGTT. In general, measurements from the 
first 10 minutes after glucose were ignored in model identification. 
The insulin sensitivity index, SI (milliliters per kg/min. μU/ml), was 




V = SIV.(6) 
SI (OGTT) is thus the oral minimal model fractional (i.e. per unit 
volume) index, SI, multiplied by the minimal model estimate of the 
glucose distribution volume, V. So defined, SI(OGTT) has the same 
units of the analogous clamp index. Parameter p1 = SG is glucose 
effectiveness: a measure of the fractional ability of glucose to lower its 
own concentration in plasma independent of increased insulin [1, 2]. 
Plasma glucose G (t) and insulin I(t) are calculated to the modified oral 
minimal model program, which estimates the model parameters from 
the experimental data. This model program is based on the nonlinear 
least-squares estimation method. Initial plasma glucose, G0 = Gb, and 
insulin, I0 = Ib, are entered in the model program, which predicts a 
glucose levels time course, G(t), which fits data G(t) as closely as 
possible in the nonlinear least-squares senses. Throughout the fitting, 
the model yields X(t), an estimate of X(t), as well as estimates of 
parameters p1, p2 and p3. The coefficient of determination, R2 is 
calculated from parameter estimates. This latter parameter is 
represented as SI and SG are equal to p3/p2 and p1 as defined in 
equations (1) and (2), is the prediction of the non-linear least-squares 
fitting. The residuals between the best-fitting curve and the data [6]: 










The estimated values for plasma glucose showed a significant 
correlation in the published data [3, 4] (see fig.1, fig. 2 and fig. 3). 
The averaged coefficient of determination, R2, value between 
measured and calculated plasma glucose concentrations is 0.960, 
which indicates excellent agreement. 
The important finding of this work is the accuracy of extrapolation 
values of 0 to 200 min. In daily practice, the sampling of blood-glucose 
most often used to examine metabolic dynamics, apart from diagnosing 
diabetes, is 0, 30, 60, 120 and 180 min. Consequently, it is important to 
extrapolate values to 200 min. Glucose concentrations during the test do 
not change bio physically within a period of 30 min, and they hardly 
change biophysically within a period of 60 min after the start with the 
test. Thus, when values at 0, 30, 60, 120, and 180 min are obtained, it is 
not difficult to interpolate other data points. 
 
 
Fig. 1: Profile of normal glucose tolerance (NGT) in [3, 4] 
produced by equations (1)-(7) with parameters: k = 0.105, γ = 
0.0014, Gb = 80 [mg/dl], Ib = 8 [μU/ml], p2 = 0.025 [min-1], SI = 
11.86 × 10-4 [ml/kg/min. μU/ml], SG = 0.026 [min-1], I0 = 10 
[μU/ml], G0 = 85 [mg/dl], and R2= 0.960 
 
 
Fig. 2: Profile of impaired glucose tolerance (IGT) in [3, 4] 
produced by equations (1)-(7) with parameters: k = 0.72, γ = 
0.019, Gb = 95 [mg/dl], Ib = 11 [μU/ml], p2 = 0.00115 [min-1], SI = 
10.7 × 10-4 [ml/kg/min. μU/ml], SG = 0.027 [min-1], I0 = 12 
[μU/ml], G0 = 100 [mg/dl], and R2= 0.960 
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The values at 180 min have large variations in all subjects (see fig. 1, 
fig. 2 and fig. 3). One of the reasons is that the rate of appearance of 
exogenous glucose in plasma varies greatly at 180 min. Another 
reason is that insulin-dependent glucose uptake contributes to 
glucose regulation at 180 min, where the glucose levels do not 
return to the basal level and insulin secretion is still stimulated. 
Therefore, if glucose level at 180 min can be reasonably extrapolated 
from values within 120 min, it means that those models can be used 
even from values at 0, 30, 60, and 120 min. This 120 min 4sample of 
glucose levels is expected to facilitate the model assessment of 
diabetes in daily practice. The distinguishing feature of the proposed 
procedure for the reduction of samples is that the original 
information of clinical data is maintained by the extrapolation. It is 
reported for non-diabetic subjects that the reproducibility of the 
model parameters was good between the full sampling and reduced 
sampling protocols, but it might not be accurate for diabetic patients 
as well as non-diabetic cases since it loses the informative variation 
at 180 min. 
 
Fig. 3: Profile of diabetes mellitus (DM) in [3, 4] produced by 
equations (1)-(7) with parameters: k = 0.13, γ = 0.00081, Gb = 
143 [mg/dl], Ib = 13 [μU/ml], p2 = 0.07 [min-1], SI = 1.85×10-4 
[ml/kg/min. μU/ml], SG = 0.010 [min-1], I0 = 13 [μU/ml], G0 = 110 
[mg/dl], and R2 = 0.960 
 
In this study, a modified oral minimal model has been proposed that 
can estimate insulin sensitivity (SI) in a given subject from plasma 
glucose concentration measured after an oral glucose perturbation, 
by simultaneously reconstructing also the rate of appearance of the 
absorbed glucose (Rα). We have validated the modified oral minimal 
model against what can be considered today the state-of-art 
reference method for estimating insulin sensitivity during a meal or 
an OGTT test. In table 2, insulin sensitivity (SI) of the IGT and T2DM 
subjects is smaller than the NGT, likewise glucose effectiveness (SG) 
of the T2DM subjects also is smaller than the NGT and IGT. This 
information is provided that the SI and SG measured by the modified 
oral minimal model can be used a diagnosis IGT and T2DM subjects.  
 
Table 2: Parameters of OGTT using modified oral minimal 
model 
 NGT IGT T2MD 
SI [ml/kg/min. μU/ml] 11.86 × 10-4 10.7 × 10-4 1.85×10-4 
SG[min-1] 0.026 0.027 0.010 
Gb[mg/dl] 80 95 143 
Ib[μU/ml] 8 12 13 
 
DISCUSSION 
Insulin sensitivity measures the ability of insulin to inhibit glucose 
production and enhance glucose utilization. It is used in clinical and 
epidemiological studies to quantify insulin resistance as a risk factor 
for pathological conditions, such as obesity and hypertension, and to 
assess the efficacy of a given therapy. Insulin sensitivity is usually 
estimated using intravenous administration of glucose and/or 
insulin, such as the glucose clamp technique or the IVGTT 
interpreted with the modified minimal model [1, 2]. However, both 
techniques’ measure insulin sensitivity by experimentally creating a 
non-physiological milieu, and it would be important to be able to 
measure this parameter in a normal-life physiological milieu, e. g., 
during a meal. 
The OGTT is generally considered as more sensitive for the 
screening of impaired glycemia, because it detects changes in post-
prandial glycemia that tend to precede changes in fasting glucose. 
There are no references except a previous report [3, 7] and this 
research for blood-glucose values to the OGTT time points of 0, 30, 
60, 120, and 180 min. Similarly to Lu et al. [3] and Zhou et al. [7], we 
noted that a large proportion as the NGT subjects screened had a 
very interesting glucose profile as follows: (i) while the fasting and 
180 min plasma glucose concentrations were below the IGT, the 60 
min glucose concentration was in contrast above 200 mg/dl, and (ii) 
while the fasting and 180 min plasma glucose concentrations were 
below the and T2DM, the 60 min glucose concentration was in 
contrast strikingly abnormal (330 mg/dl). Conceptually, 30 to 60 
min after the ingestion of a meal (bolus glucose), not several hours 
afterwards, represents the peak point of metabolic and digestive 
events and therefore, potentially is a better time to choose for the 
detection of the earliest signs of metabolic dysfunction.  
Moreover, in temporal terms at least, what happens at 60 min is 
bound to affect the 120 min glucose concentration (spill over effect) 
and not vice versa. Obviously, one way to determine the significance 
of the 60 min glucose concentration would be to study these subjects 
prospectively to determine the natural history of the glucose 
abnormality in relation with the development of diabetic 
complications. 
Glucose and insulin concentrations at 200 min during the OGTT 
were extrapolated using a nonlinear least-squares method. The 
OGTT data from subjects in various stages of glucose tolerance were 
analyzed to evaluate the estimation accuracy. As a result, it 
estimated values for glucose concentration showed the good 
correlation to the reference data [3, 4]. The results showed that the 
180 min 4sample of blood glucose be combined with a nonlinear 
least-squares method could provide a reasonable basis to enhance 
the use of the modified oral minimal model approach to diabetes 
care. This result also indicates that a reduction in clinical testing is 
possible by using the computational approach. 
CONCLUCION 
In this present model, the new insulin system is described by a one-
compartment model [1, 2]. On the previous references [5], equation 
insulin not explained. Insulin secretion is assumed to be dependent 
on both plasma glucose concentration and its rate of change. We 
have proposed a physiologically based model to the glucose-insulin 
system during meals. The model strategy has taken advantage of a 
unique meal data set in NGT, IGT and T2DM subjects. 
We conclude that the measurement of blood glucose levels during an 
OGTT at time points in 0 to 120 min provides additional valuable 
information on the glucose metabolism. 
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